Literature DB >> 19658001

Tetraspanin CD9 is required for microparticle release from coated-platelets.

George L Dale1, Gyula Remenyi, Paul Friese.   

Abstract

CD9, a member of the tetraspanin superfamily, is the third most abundant protein on the platelet surface, but its function remains unknown. In this report, we demonstrate that CD9 is required for the release of microparticles from coated-platelets. Coated-platelets are formed as a result of dual agonist activation with collagen and thrombin, and each coated-platelet releases 15-25 microparticles averaging 0.4 microm in diameter. We report here that four separate monoclonal antibodies against CD9 inhibited microparticle release from coated-platelets by 72-102% with an IC(50) of approximately 500 ng/mL for ALB6 and SN4. In addition, the anti-alpha(IIb)beta(3) monoclonal antibody AP2 also inhibited microparticle release although additional anti-alpha(IIb)beta(3) monoclonals did not. These data support participation of the tetraspanin CD9, together with the integrin alpha(IIb)beta(3), in the membrane vesiculation process associated with platelet microparticle release.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19658001     DOI: 10.1080/09537100903096692

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  9 in total

1.  Overexpression of CD9 correlates with tumor stage and lymph node metastasis in esophageal squamous cell carcinoma.

Authors:  Jian Huan; Yi Gao; Jing Xu; Wenjiong Sheng; Wei Zhu; Shuyu Zhang; Jianping Cao; Jiang Ji; Liyuan Zhang; Ye Tian
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

2.  Socially Distanced Intercellular Communication: Mechanisms for Extracellular Vesicle Cargo Delivery.

Authors:  Stephanie J Popa; Sarah E Stewart
Journal:  Subcell Biochem       Date:  2021

Review 3.  Microvesicles as mediators of tissue regeneration.

Authors:  Keith Sabin; Nobuaki Kikyo
Journal:  Transl Res       Date:  2013-10-25       Impact factor: 7.012

4.  Transcriptomic signatures in whole blood of patients who acquire a chronic inflammatory response syndrome (CIRS) following an exposure to the marine toxin ciguatoxin.

Authors:  James C Ryan; Qingzhong Wu; Ritchie C Shoemaker
Journal:  BMC Med Genomics       Date:  2015-04-02       Impact factor: 3.063

5.  Platelet extracellular vesicles induce a pro-inflammatory smooth muscle cell phenotype.

Authors:  Tanja Vajen; Birke J Benedikter; Alexandra C A Heinzmann; Elena M Vasina; Yvonne Henskens; Martin Parsons; Patricia B Maguire; Frank R Stassen; Johan W M Heemskerk; Leon J Schurgers; Rory R Koenen
Journal:  J Extracell Vesicles       Date:  2017-05-16

Review 6.  Platelets Extracellular Vesicles as Regulators of Cancer Progression-An Updated Perspective.

Authors:  Magdalena Żmigrodzka; Olga Witkowska-Piłaszewicz; Anna Winnicka
Journal:  Int J Mol Sci       Date:  2020-07-22       Impact factor: 5.923

7.  Circulating CD81-expressing extracellular vesicles as biomarkers of response for immune-checkpoint inhibitors in advanced NSCLC.

Authors:  Diego Signorelli; Patrizia Ghidotti; Claudia Proto; Marta Brambilla; Alessandro De Toma; Roberto Ferrara; Giulia Galli; Monica Ganzinelli; Giuseppe Lorusso; Arsela Prelaj; Mario Occhipinti; Giuseppe Viscardi; Valentina Capizzuto; Francesca Pontis; Ilaria Petraroia; Anna Maria Ferretti; Mario Paolo Colombo; Valter Torri; Gabriella Sozzi; Marina Chiara Garassino; Elena Jachetti; Orazio Fortunato
Journal:  Front Immunol       Date:  2022-09-20       Impact factor: 8.786

Review 8.  Extracellular vesicles derived from mesenchymal stromal cells: a therapeutic option in respiratory diseases?

Authors:  Soraia C Abreu; Daniel J Weiss; Patricia R M Rocco
Journal:  Stem Cell Res Ther       Date:  2016-04-14       Impact factor: 6.832

Review 9.  Function of Platelet Glycosphingolipid Microdomains/Lipid Rafts.

Authors:  Keisuke Komatsuya; Kei Kaneko; Kohji Kasahara
Journal:  Int J Mol Sci       Date:  2020-08-02       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.